Buyer Class Still Valid In Nifedipine Antitrust Suit

Law360, New York (February 24, 2009, 12:00 AM EST) -- A federal appeals court has decided not to review the class status of a group of direct purchasers that accused Biovail Corp., Elan Corp. PLC and Teva Pharmaceuticals Ltd. of conspiring to restrain the sale of nifedipine, a generic version of hypertension drug Adalat CC.

In a per curium order issued Monday, a three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit denied the defendants' petition for leave to appeal the granting of class certification.

“It's an interlocutory appeal, so they...
To view the full article, register now.